DBVT opened at $6.20 on Friday. DBV Technologies has a 12 month low of $2.20 and a 12 month high of $8.32. The stock has a market capitalization of $127.53 million, a P/E ratio of -1.38 and a beta ...

DBV Technologies secured up to $306.9M to advance its Viaskin Peanut program. The funding supports FDA submission, commercialization and ongoing pediatric peanut allergy treatment research. Feel ...

Clinical-stage biopharmaceutical company DBV Technologies (NASDAQ:DBVT) announced a financing of up to $306.9M (€284.5M), including gross proceeds of $125.5M (€116.3M) to be received upon ...

American depositary receipts of DBV Technologies gained after the company reported new financing of up to $306.9 million. The biopharmaceutical company's ADRs were up 57%, at $6.14, Friday morning.

If you are planning to travel to Dubrovnik or any other city in Croatia, this airport locator will be a very useful tool. This page gives complete information about the Dubrovnik Airport along with ...

Today, a brief rundown of news involving Novo Nordisk and DBV Technologies, as well as updates from Arbutus Biopharma, Bicycle Therapeutics and CRISPR Therapeutics that you may have missed. Aurion is ...